drugset / Trial / NCT03235362

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706

NCT03235362 ↗

Phase 1 Completed 28 enrolled Yuhan Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

This is a phase 1, open label, multiple-dose, crossover clinical trial to investigate the pharmacokinetic drug interaction between YHR1705 and YHR1706 in healty male volunteers

Timeline

Start
2017-08-07
Primary completion
2017-09-19
Completion
2017-09-19

Drugs

EvaluationDrugModalityDoseRoute
Subject YHR1705 Unknown — Oral
Subject YHR1706 Unknown — Oral